EVOK Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Evoke Pharma Inc

Watchlist Manager

Watchlist

Price: 29.9 USD 2.93% Market Closed

Market Cap: $25.5m

	Evoke Pharma Inc NASDAQ:EVOK	US
H	HucenTech Co Ltd KOSDAQ:215090	KR
S	SSR Inc KOSDAQ:275630	KR
	Ecoslops SA PAR:ALESA	FR

Profitability Summary

Evoke Pharma Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

97%

Strong 3Y Average Gross Margin

96%

Gross Margin is Increasing

89% > 97%

Negative Operating Margin

-36%

Negative 3Y Average Operating Margin

-83%

Operating Margin is Increasing

-212% > -36%

Negative Net Margin

-36%

Negative 3Y Average Net Margin

-86%

Net Margin is Increasing

-222% > -36%

Negative Free Cash Flow Margin

-23%

Negative 3Y Average Free Cash Flow Margin

-68%

Free Cash Flow Margin is Increasing

-181% > -23%

Negative ROE

-135%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-1 090%

ROIC is Increasing

-2 224% > -1 325%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

97%

Strong 3Y Average Gross Margin

96%

Gross Margin is Increasing

89% > 97%

Negative Operating Margin

-36%

Negative 3Y Average Operating Margin

-83%

Operating Margin is Increasing

-212% > -36%